These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 3118852)
1. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity. Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852 [TBL] [Abstract][Full Text] [Related]
2. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. IV. Lymph node immunoreactivity and cell-mediated cytotoxicity. Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P Neoplasma; 1987; 34(4):431-9. PubMed ID: 3116439 [TBL] [Abstract][Full Text] [Related]
3. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. III. Morphometric assessment of the dynamic changes in post-capillary venules as regulatory elements of lymphocyte recirculation in tumor-draining lymph nodes. Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R Arch Geschwulstforsch; 1987; 57(1):7-15. PubMed ID: 3105513 [TBL] [Abstract][Full Text] [Related]
4. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice. Takei F; Levy JG; Kilburn DG J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160 [TBL] [Abstract][Full Text] [Related]
5. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect. Igarashi T; Okada M; Kishimoto S; Yamamura Y Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916 [TBL] [Abstract][Full Text] [Related]
6. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. VI. Histamine-induced suppression of in vitro generation of tumour-specific cytotoxic T cells. Laatikainen A Scand J Immunol; 1989 Oct; 30(4):449-55. PubMed ID: 2510290 [TBL] [Abstract][Full Text] [Related]
7. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. II. Morphometric assessment of immunoreactivity in the thymus and spleen related to lymphocyte subsets in peripheral blood. Syrjänen K; Tosi P; Cintorino M; Mäntyjärvi R; Luzi P; Leoncini L; Laatikainen A; Miracco C; Santopietro R Exp Pathol; 1986; 30(2):75-82. PubMed ID: 3096774 [TBL] [Abstract][Full Text] [Related]
8. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
9. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens. Bear HD Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451 [TBL] [Abstract][Full Text] [Related]
10. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. I. Morphometric assessment of lymph node immunoreactivity and analysis of circulating antibodies. Tosi P; Syrjänen K; Cintorino M; Mäntyjärvi R; Luzi P; Miracco C; Laatikainen A; Leoncini L; Santopietro R Exp Pathol; 1986; 30(2):65-74. PubMed ID: 3096773 [TBL] [Abstract][Full Text] [Related]
11. Effects of two bisdioxopiperazines on mouse B-and T-cell function. Dennert G; Hatlen LE; Tucker DF J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564 [TBL] [Abstract][Full Text] [Related]
12. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma. Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630 [TBL] [Abstract][Full Text] [Related]
13. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice. Germain RN; Williams RM; Benacerraf B Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167 [TBL] [Abstract][Full Text] [Related]
15. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response. Kölsch E Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139 [TBL] [Abstract][Full Text] [Related]
16. Helper cells active in the generation of cytotoxicity to a syngeneic tumor. Hancock EJ; Kilburn DG; Levy JG J Immunol; 1981 Oct; 127(4):1394-7. PubMed ID: 6168688 [TBL] [Abstract][Full Text] [Related]
17. Activation of suppressor cells by syngeneic tumor transplants in mice. Argyris BF Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732 [TBL] [Abstract][Full Text] [Related]
18. Characterization of suppressor cells in mice bearing syngeneic mastocytoma. Takei F; Levy JG; Kilburn DG J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423 [TBL] [Abstract][Full Text] [Related]
19. Restoration of in vitro immune responsiveness of mastocytoma-suppressed splenocytes by activated T cells. Kamo I; Patel C; Patel N; Friedman H J Immunol; 1975 Aug; 115(2):382-6. PubMed ID: 807635 [TBL] [Abstract][Full Text] [Related]
20. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2. Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]